Wednesday, January 06, 2021 10:58:18 AM
Recent ORTX News
- Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy • GlobeNewswire Inc. • 03/20/2024 11:00:07 AM
- Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S. • GlobeNewswire Inc. • 03/18/2024 07:41:13 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 02:05:44 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/05/2024 07:39:49 PM
- Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome • GlobeNewswire Inc. • 02/05/2024 12:00:03 PM
- Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium • GlobeNewswire Inc. • 02/02/2024 12:00:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/31/2024 05:15:12 AM
- Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy • GlobeNewswire Inc. • 01/25/2024 12:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:18:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:17:53 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/24/2024 09:41:53 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 09:28:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:17:00 PM
- Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases • GlobeNewswire Inc. • 01/24/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:10:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:49:53 PM
- Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD • GlobeNewswire Inc. • 12/11/2023 12:00:17 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM